{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06423703",
            "orgStudyIdInfo": {
                "id": "TRN-228-302"
            },
            "organization": {
                "fullName": "Tris Pharma, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy",
            "officialTitle": "A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Efficacy and Safety of Cebranopadol for the Treatment of Moderate to Severe Acute Pain After Primary Unilateral Bunionectomy",
            "acronym": "ALLEVIATE2",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-study-of-cebranopadol-for-the-treatment-of-acute-pain-after-bunionectomy"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-05",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-05-16",
            "studyFirstSubmitQcDate": "2024-05-16",
            "studyFirstPostDateStruct": {
                "date": "2024-05-21",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-21",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-23",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Tris Pharma, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to evaluate the efficacy and safety of Cebranopadol for acute pain after a bunionectomy.",
            "detailedDescription": "This study is a Phase 3, multicenter, randomized, double-blind, placebo- and active-controlled parallel-group study to evaluate the efficacy and safety of cebranopadol in the treatment of postoperative pain following primary unilateral bunionectomy with first metatarsal osteotomy. The study will be conducted in 3 phases: Screening, Treatment, and Follow-up."
        },
        "conditionsModule": {
            "conditions": [
                "Acute Pain"
            ],
            "keywords": [
                "Bunionectomy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 240,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Cebranopadol",
                    "type": "EXPERIMENTAL",
                    "description": "once daily for 3 days",
                    "interventionNames": [
                        "Drug: Cebranopadol",
                        "Drug: Placebo"
                    ]
                },
                {
                    "label": "Oxycodone IR",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "four times per day for 3 days",
                    "interventionNames": [
                        "Drug: Oxycodone IR"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "three times per day 3 days (with cebranopadol); four times per day for 3 days (placebo arm)",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Cebranopadol",
                    "description": "once daily for 3 days",
                    "armGroupLabels": [
                        "Cebranopadol"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Oxycodone IR",
                    "description": "four times per day for 3 days",
                    "armGroupLabels": [
                        "Oxycodone IR"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "three times per day 3 days (with cebranopadol), four times per day for 3 days (placebo arm)",
                    "armGroupLabels": [
                        "Cebranopadol",
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Pain NRS area under the curve: cebranopadol vs. placebo",
                    "timeFrame": "2-48 hours"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Proportion of subjects who require opioid rescue medication",
                    "timeFrame": "0-72 hours"
                },
                {
                    "measure": "Global Assessment of Satisfaction",
                    "timeFrame": "0-72 hours"
                },
                {
                    "measure": "Total oxycodone rescue consumption",
                    "timeFrame": "0-72 hours"
                }
            ],
            "otherOutcomes": [
                {
                    "measure": "Incidence of Respiratory Safety Events",
                    "timeFrame": "0-72 hours"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria Before Surgery:\n\n* Scheduled to undergo primary unilateral bunionectomy with first metatarsal osteotomy and internal fixation with no collateral procedures, using anesthesiologic and surgical procedures planned\n* Must be able to adhere to the visit schedule, complete all study assessments and protocol requirements, including self-reported questionnaires.\n\nKey Exclusion Criteria Before Surgery:\n\n* Any clinically significant disease, medical condition, or laboratory finding that in the investigator's opinion may interfere with the study procedures or data integrity, or compromise the safety of the subject.\n* Secondary (i.e., unrelated to bunion) current painful condition that could confound the interpretation of efficacy, safety, or tolerability data in the study, in the opinion of the investigator.\n* Subjects who require any analgesic for secondary (i.e., unrelated to bunion) painful condition that might impact the subject's ability to properly assess their postoperative pain, or that may require treatment during the Treatment Phase.\n* History of allergy or hypersensitivity to any opioid analgesics, anesthetics, ibuprofen, or other NSAIDs.\n\nImmediate Postoperative Exclusion Criteria:\n\n* Surgical, postsurgical, or anesthetic complication that could confound the interpretation of efficacy, safety, or tolerability data in the study.\n* Deviation from the surgical, postsurgical, or anesthetic protocol that could confound the interpretation of efficacy, safety, or tolerability data in the study.\n* Evidence of hemodynamic instability or respiratory insufficiency.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "75 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Antonio Pardo, MD",
                    "role": "CONTACT",
                    "phone": "732-823-4755",
                    "email": "clinicalaffairs@trispharma.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Todd M Bertoch, MD",
                    "affiliation": "CenExel JBR",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "ALLEVIATE 2 Site 001108",
                    "city": "Sheffield",
                    "state": "Alabama",
                    "zip": "35660",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.76509,
                        "lon": -87.69864
                    }
                },
                {
                    "facility": "ALLEVIATE 2 Site 001106",
                    "city": "Little Rock",
                    "state": "Arkansas",
                    "zip": "72211",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.74648,
                        "lon": -92.28959
                    }
                },
                {
                    "facility": "ALLEVIATE 2 Site 001103",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33613",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "ALLEVIATE 2 Site 001102",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30331",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "ALLEVIATE 2 Site 001107",
                    "city": "Overland Park",
                    "state": "Kansas",
                    "zip": "66212",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.98223,
                        "lon": -94.67079
                    }
                },
                {
                    "facility": "ALLEVIATE 2 Site 001105",
                    "city": "Pasadena",
                    "state": "Maryland",
                    "zip": "21122",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.10733,
                        "lon": -76.57108
                    }
                },
                {
                    "facility": "ALLEVIATE 2 Site 001104",
                    "city": "McAllen",
                    "state": "Texas",
                    "zip": "78501",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.20341,
                        "lon": -98.23001
                    }
                },
                {
                    "facility": "ALLEVIATE 2 Site 001101",
                    "city": "Salt Lake City",
                    "state": "Utah",
                    "zip": "84107",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.76078,
                        "lon": -111.89105
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000059787",
                    "term": "Acute Pain"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010146",
                    "term": "Pain"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                },
                {
                    "id": "M29525",
                    "name": "Acute Pain",
                    "asFound": "Acute Pain",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "T170",
                    "name": "Acute Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000010098",
                    "term": "Oxycodone"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000701",
                    "term": "Analgesics, Opioid"
                },
                {
                    "id": "D000009294",
                    "term": "Narcotics"
                },
                {
                    "id": "D000002492",
                    "term": "Central Nervous System Depressants"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13020",
                    "name": "Oxycodone",
                    "asFound": "Where",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4033",
                    "name": "Analgesics, Opioid",
                    "relevance": "LOW"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M12245",
                    "name": "Narcotics",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}